scispace - formally typeset
A

Angel Cedazo-Minguez

Researcher at Karolinska Institutet

Publications -  118
Citations -  6879

Angel Cedazo-Minguez is an academic researcher from Karolinska Institutet. The author has contributed to research in topics: Presenilin & Protein kinase C. The author has an hindex of 40, co-authored 112 publications receiving 5852 citations. Previous affiliations of Angel Cedazo-Minguez include Karolinska University Hospital.

Papers
More filters
Journal ArticleDOI

Defeating Alzheimer's disease and other dementias: a priority for European science and society

TL;DR: This poster aims to demonstrate the efforts towards in-situ applicability of EMMARM, which aims to provide real-time information about the physical and cognitive properties of Alzheimer's disease and other dementias.
Journal ArticleDOI

DJ-1 acts in parallel to the PINK1/parkin pathway to control mitochondrial function and autophagy

TL;DR: It is shown that loss of DJ-1 leads to loss of mitochondrial polarization, fragmentation of mitochondria and accumulation of markers of autophagy around mitochondria in human dopaminergic cells, and data suggest thatDJ-1 works in parallel to the PINK1/parkin pathway to maintain mitochondrial function in the presence of an oxidative environment.
Journal ArticleDOI

Oxysterols and neurodegenerative diseases

TL;DR: The possibility that the flux of 27-OHC from the circulation into the brain represents the missing link between AD and hypercholesterolemia is explored, and the possibility that modification of this flux may be a therapeutic strategy is discussed.
Journal ArticleDOI

Apolipoprotein E epsilon 4 magnifies lifestyle risks for dementia: a population-based study

TL;DR: Physical inactivity, dietary fat intake, alcohol drinking and smoking at midlife are associated with the risk of dementia and AD, especially among the apoE ɛ4 carriers, and thus, lifestyle interventions may greatly modify dementia risk particularly among the genetically susceptible individuals.
Journal ArticleDOI

Oxidative Stress in Alzheimer’s Disease: Why Did Antioxidant Therapy Fail?

TL;DR: The current knowledge about oxidative stress in AD pathogeny is reviewed and future paths that are worth to be explored in animal models and clinical studies are suggested in order to get a better approach of oxidative imbalance in this inexorable neurodegenerative disease.